Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Schulz, Rainer; ter Ferdinandy, Pé; Görge, Philipp Maximilian; Görbe, Anikó; Ferdinandy, Péter; Lampe, Paul D.; Leybaert, Luc

Published in

Elsevier, Pharmacology and Therapeutics, (153), p. 90-106, 2015

DOI: 10.1016/j.pharmthera.2015.06.005

Tools

Export citation

Search in Google Scholar

Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Journal article published in 2015 by Rainer Schulz, Pé ter Ferdinandy, Philipp Maximilian Görge, Anikó Görbe, Péter Ferdinandy, Paul D. Lampe, Luc Leybaert

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.